DOI QR코드

DOI QR Code

Effect of caffeine on the antibacterial activity of Lactobacillus casei: caffeine and antibacterial activity of L. casei

  • Jang, Eunjeong (Division of Life Science and Chemistry, College of Natural Science, Daejin University) ;
  • Park, Jin A (Division of Life Science and Chemistry, College of Natural Science, Daejin University) ;
  • Kim, Young Ha (Division of Life Science and Chemistry, College of Natural Science, Daejin University) ;
  • Kim, Ho (Division of Life Science and Chemistry, College of Natural Science, Daejin University)
  • Received : 2019.06.18
  • Accepted : 2019.08.22
  • Published : 2019.12.31

Abstract

Coffee is a popular beverage worldwide, and the scale of consumption is growing rapidly. Many studies have shown that increased coffee consumption has various effects on human health, including beneficial effects on liver diseases, clinical type 2 diabetes, and Parkinson's disease. However, the influences of coffee or caffeine (a component of coffee) on the gut microbiota have not been examined in detail. Here, we tested whether caffeine could alter the antimicrobial activity of L. casei against E. coli. Interestingly, we found that treatment with 0.3 mg/mL caffeine increased the antimicrobial activity of L. casei against E. coli. This activity was not associated with the release of lactic acid but did appear to be related to a heat-labile factor present in the L. casei culture supernatant. Our analyses suggest that the putative antimicrobial factor found in the culture supernatant of L. casei treated with caffeine may be bacteriocin. Taken together, our results suggest that caffeine, which is an ingredient of coffee, increases the antimicrobial activity of L. casei against E. coli through the enhanced production of bacteriocin. These findings also suggest that coffee consumption affects the ability of beneficial bacteria to decrease pathogenic bacteria and/or prevent the progression of bacterial infection-associated diseases in the gut.

Keywords

References

  1. Al-Janabi AA. 2011. Potential activity of the purine compounds caffeine and aminophylline on bacteria. Journal of Global Infectious Diseases 3:133-137. https://doi.org/10.4103/0974-777X.81689
  2. Bellavia M, Rappa F, Lo Bello M, Brecchia G, Tomasello G, Leone A, Spatola G, Uzzo ML, Bonaventura G, David S, Damiani P, Hajj Hussein I, Zeenny MN, Jurjus A, Schembri-Wismayer P, Cocchi M, Zummo G, Farina F, Gerbino A, Cappello F, Traina G. 2014. Lactobacillus casei and bifidobacterium lactis supplementation reduces tissue damage of intestinal mucosa and liver after 2,4,6-trinitrobenzenesulfonic acid treatment in mice. Journal of Biological Regulators and Homeostatic Agents 28:251-261.
  3. Betrosian AP, Douzinas EE. 2009. Ampicillin-sulbactam: an update on the use of parenteral and oral forms in bacterial infections. Expert Opinion on Drug Metabolism & Toxicology 5:1099-1112. https://doi.org/10.1517/17425250903145251
  4. Caballero-Guerrero B, Lucena-Padros H, Maldonado-Barragan A, Ruiz-Barba JL. 2013. High-salt brines compromise autoinducer-mediated bacteriocinogenic Lactobacillus plantarum survival in Spanishstyle green olive fermentations. Food Microbiology 33:90-96. https://doi.org/10.1016/j.fm.2012.09.002
  5. Escribano J, Ferre N, Gispert-Llaurado M, Luque V, Rubio-Torrents C, Zaragoza-Jordana M, Polanco I, Codoner FM, Chenoll E, Morera M, Moreno-Munoz JA, Rivero M, Closa-Monasterolo R. 2018. Bifidobacterium longum subsp infantis CECT7210-supplemented formula reduces diarrhea in healthy infants: a randomized controlled trial. Pediatric Research 83:1120-1128. https://doi.org/10.1038/pr.2018.34
  6. Falagas ME, Grammatikos AP, Michalopoulos A. 2008. Potential of old-generation antibiotics to address current need for new antibiotics. Expert Review of Anti-infective Therapy 6:593-600. https://doi.org/10.1586/14787210.6.5.593
  7. Ghadbane M, Harzallah D, Laribi AI, Jaouadi B, Belhadj H. 2013. Purification and biochemical characterization of a highly thermostable bacteriocin isolated from Brevibacillus brevis strain GM100. Bioscience, Biotechnology, and Biochemistry 77:151-160. https://doi.org/10.1271/bbb.120681
  8. Grassl GA, Faustmann M, Gill N, Zbytnuik L, Merkens H, So L, Rossi FM, McNagny KM, Finlay BB. 2010. CD34 mediates intestinal inflammation in Salmonella-infected mice. Cellular Microbiology 12:1562-1575. https://doi.org/10.1111/j.1462-5822.2010.01488.x
  9. Gustine JN, Au MB, Haserick JR, Hett EC, Rubin EJ, Gibson FC, Deng LL. 2019. Cell wall hydrolytic enzymes enhance antimicrobial drug activity against mycobacterium. Current Microbiology 76:398-409. https://doi.org/10.1007/s00284-018-1620-z
  10. Hernan MA, Takkouche B, Caamano-Isorna F, Gestal-Otero JJ. 2002. A meta-analysis of coffee drinking, cigarette smoking, and the risk of Parkinson's disease. Annals of Neurology 52:276-284. https://doi.org/10.1002/ana.10277
  11. Inoue M, Yoshimi I, Sobue T, Tsugane S, Group JS. 2005. Influence of coffee drinking on subsequent risk of hepatocellular carcinoma: A prospective study in Japan. Journal of National Cancer Institute 97:293-300. https://doi.org/10.1093/jnci/dji040
  12. Mirnejad R, Vahdati AR, Rashidiani J, Erfani M, Piranfar V. 2013. The antimicrobial effect of lactobacillus casei culture supernatant against multiple drug resistant clinical isolates of Shigella sonnei and Shigella flexneri in vitro. Iranian Red Crescent Medical Journal 15:122-126. https://doi.org/10.5812/ircmj.7454
  13. Mitchell C, Balkus J, Agnew K, Lawler R, Hitti J. 2009. Changes in the vaginal microenvironment with metronidazole treatment for bacterial vaginosis in early pregnancy. Journal of Women's Health 18:1817-1824. https://doi.org/10.1089/jwh.2009.1378
  14. Moeinian M, Ghasemi-Niri SF, Mozaffari S, Abdolghaffari AH, Baeeri M, Navaea-Nigjeh M, Abdollahi M. 2014. Beneficial effect of butyrate, Lactobacillus casei and L-carnitine combination in preference to each in experimental colitis. World Journal of Gastroenterology 20:10876-10885. https://doi.org/10.3748/wjg.v20.i31.10876
  15. Nakayama T, Oishi K. 2013. Influence of coffee (Coffea arabica) and galacto-oligosaccharide consumption on intestinal microbiota and the host responses. FEMS Microbiology Letters 343:161-168. https://doi.org/10.1111/1574-6968.12142
  16. Ritter SC, Yang ML, Kaznessis YN, Hackel BJ. 2018. Multispecies activity screening of microcin J25 mutants yields antimicrobials with increased specificity toward pathogenic Salmonella species relative to human commensal Escherichia coli. Biotechnology and Bioengineering 115:2394-2404. https://doi.org/10.1002/bit.26772
  17. Sharma A, Srivastava S. 2014. Anti-Candida activity of two-peptide bacteriocins, plantaricins (Pln E/F and J/K) and their mode of action. Fungal Biology 118:264-275. https://doi.org/10.1016/j.funbio.2013.12.006
  18. Stalb S, Barth SA, Sobotta K, Liebler-Tenorio E, Geue L, Menge C. 2018. Pro-inflammatory capacity of Escherichia coli O104:H4 outbreak strain during colonization of intestinal epithelial cells from human and cattle. International Journal of Medical Microbiology 308:899-911. https://doi.org/10.1016/j.ijmm.2018.06.003
  19. Tagg JR, Dierksen KP. 2003. Bacterial replacement therapy: Adapting 'germ warfare' to infection prevention. Trends in Biotechnology 21:217-223. https://doi.org/10.1016/S0167-7799(03)00085-4
  20. Teng D, Wang X, Xi D, Mao R, Zhang Y, Guan Q, Zhang J, Wang J. 2014. A dual mechanism involved in membrane and nucleic acid disruption of AvBD103b, a new avian defensin from the king penguin, against Salmonella enteritidis CVCC3377. Applied Microbiology and Biotechnology 98:8313-8325. https://doi.org/10.1007/s00253-014-5898-x
  21. Thongprayoon C, Kaewput W, Hatch ST, Bathini T, Sharma K, Wijarnpreecha K, Ungprasert P, D'Costa M, Mao MA, Cheungpasitporn W. 2019. Effects of probiotics on inflammation and uremic toxins among patients on dialysis: A systematic review and meta-analysis. Digestive Diseases and Sciences 64:469-479. https://doi.org/10.1007/s10620-018-5243-9
  22. Tran KT, Coleman HG, McMenamin UC, Cardwell CR. 2019. Coffee consumption by type and risk of digestive cancer: A large prospective cohort study. British Journal of Cancer 120:1059-1066. https://doi.org/10.1038/s41416-019-0465-y
  23. Trivedi D, Jena PK, Patel JK, Seshadri S. 2013. Partial purification and characterization of a bacteriocin DT24 produced by probiotic vaginal Lactobacillus brevis DT24 and determination of its antiuropathogenic Escherichia coli potential. Probiotics and Antimicrobial Proteins 5:142-151. https://doi.org/10.1007/s12602-013-9132-4
  24. van Dam RM, Feskens EJ. 2002. Coffee consumption and risk of type 2 diabetes mellitus. Lancet 360:1477-1478. https://doi.org/10.1016/S0140-6736(02)11436-X
  25. Zelber-Sagi S, Salomone F, Webb M, Lotan R, Yeshua H, Halpern Z, Santo E, Oren R, Shibolet O. 2015. Coffee consumption and nonalcoholic fatty liver onset: A prospective study in the general population. The Journal of Laboratory and Clinical Medicine 165:428-436.